•
Jun 30, 2022

Avinger Q2 2022 Earnings Report

Avinger reported results for the second quarter ended June 30, 2022.

Key Takeaways

Avinger reported a revenue of $2.1 million for the second quarter of 2022, representing a 13% increase from the first quarter of 2022. The company's gross margin was 31%, with increased revenue levels driving a 3 percentage point improvement from the first quarter. They maintained a strong cash position of $16.0 million at June 30, 2022.

Second quarter revenue of $2.1 million, representing a 13% increase from the first quarter of 2022

Gross margin of 31%, with increased revenue levels driving a 3 percentage point improvement from the first quarter

Expanded to full commercial launch for the Lightbox 3 next-generation imaging console

Maintained a strong cash position of $16.0 million at June 30, 2022, enhanced by the addition of $5.0 million in gross proceeds raised in August 2022

Total Revenue
$2.13M
Previous year: $2.8M
-23.9%
EPS
-$14.1
Previous year: -$12
+17.5%
Gross Profit
$651K
Previous year: $1.01M
-35.4%
Cash and Equivalents
$16M
Previous year: $26.7M
-40.1%
Free Cash Flow
-$4.37M
Previous year: -$3.75M
+16.5%
Total Assets
$27.2M
Previous year: $38.2M
-28.9%

Avinger

Avinger

Forward Guidance

This news release contains forward-looking statements regarding our future performance, patient and physician benefits of our products, including from Lightbox 3, the impacts of our products on the treatment of vascular disease, our ability to successfully develop new products, including products relating to the treatment of CAD, the timing of the development of new products, the impact of products developed for the treatment of CAD on our business and results of operations, the potential success of our coronary product application and the potential submission of a 510(k) application for Pantheris LV.